drugset / Trial / NCT07514780
To Evaluate the Safety, Pharmacokinetic and Pharmacodynamics of JW0061 in Healthy Volunteers
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This clinical study is a phase 1, randomized, double-blind, placebo-controlled, dose escalation clinical trial to evaluate the safety, pharmacokinetic and pharmacodynamics of JW0061 following topical application in Korean and Caucasians healthy adults.
Timeline
- Start
- 2026-04-13
- Primary completion
- 2026-12-31
- Completion
- 2027-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JW0061 | Unknown | — | — |
Indications
No indication recorded.